Am J Transplant, Volume 19, Suppl 3 Archives - Page 138 of 214 - ATC Abstracts

2019 American Transplant Congress
How Well Do Kidney Transplant Patients Understand Their Medications and Does Real-Time Assessment of Knowledge Improve Retention of Information?
B. Clark¹, B. Sirandas¹, T. Larson², A. Carlson¹, C. Truax¹, D. D. Ramirez¹, L. Smith¹, I. Hall¹
¹University of Utah Health, Salt Lake City, UT, ²Henry Ford Hospital, Detroit, MI
*Purpose: This study aims to evaluate the impact that early formal assessment and reteaching have on patient medication knowledge after renal transplant.*Methods: This was a…
2019 American Transplant Congress
Effect of Race and Antibody-Mediated Injury on Outcomes after Early Subclinical Inflammation
E. P. Kasik, M. E. Seifert, M. Bernard, G. Agarwal, H. Fatima, R. Gaston, B. Julian, C. Kew, V. Kumar, S. Mehta, S. Ong, F. Rosenblum, G. Towns, R. B. Mannon
University of Alabama, Birmingham, AL
*Purpose: The impact of subclinical inflammation (SCI) on transplant outcomes has been variable, based on previous studies in homogeneous cohorts with relatively low immunologic risk.…
2019 American Transplant Congress
Long Term Outcomes of Patients Transplanted for Hepatocellular Carcinoma with Human Immunodeficiency Virus Infection
R. Gedaly-Eidelman, E. Chacon, P. Eman, M. Gupta, J. Berger, A. El-Husseini, X. Mei, F. Marti, L. Turcios, M. Shah
University of Kentucky, Lexington, KY
*Purpose: Several studies have reported that HIV+ patients are 4-6 times more likely to develop HCC than uninfected individuals. Our aim was to assess outcomes…
2019 American Transplant Congress
Assessing the Effectiveness of Early Maintenance Immunosuppression Practices in Liver Transplantation
T. Bittermann, R. Hubbard, J. Lewis, D. Goldberg
University of Pennsylvania, Philadelphia, PA
*Purpose: Evidence regarding the efficacy of maintenance immunosuppression (IS) regimens for liver transplantation (LT) arise from clinical trials. However, the ‘real world’ effectiveness of such…
2019 American Transplant Congress
Treg Lymphotoxin and Lymphatic Endothelial Cell Lymphotoxin Receptor Interactions Are Required for Treg Stability and Allograft Protection
V. Saxena, W. Piao, L. Li, C. M. Palusckievicz, Y. Xiong, T. Simon, J. S. Bromberg
U Maryland, Baltimore, MD
*Purpose: Regulatory T cells (Treg) restrain allograft rejection through suppressor functions that are dependent upon expression of the transcription factor Foxp3, their proper migration, and…
2019 American Transplant Congress
Novel In Vitro Germinal Center Culture System Demonstrates More Aggressive B Cell to Plasma Blast Differentiation in Allosensitized Nonhuman Primates
P. Schroder, J. Yoon, R. Schmitz, Z. Fitch, J. Kwun, S. J. Knechtle
Department of Surgery, Duke University Medical Center, Durham, NC
*Purpose: The allogeneic humoral immune response is largely composed of T cell dependent antibody responses produced after B and T cells interact within the germinal…
2019 American Transplant Congress
The Association of Health Literacy with Physical and Mental Health-Related Quality of Life in Organ Transplant Candidates
K. Chapin¹, S. Rega¹, L. Dageforde², D. Moore¹, M. Via¹, I. D. Feurer¹
¹Vanderbilt Transplant Center, Vanderbilt University Medical Center, Nashville, TN, ²Transplant Surgery, Massachusetts General Hospital, Boston, MA
*Purpose: This study aimed to determine the association of health literacy with pre-transplant health-related quality of life (HRQOL) in adults evaluated for potential listing for…
2019 American Transplant Congress
Economic Evaluation of Kidney Transplantation in the Elderly Stratified by Donor Quality
M. Kadatz¹, S. Klarenbach², J. S. Gill¹, J. Gill¹
¹Nephrology, University of British Columbia, Vancouver, BC, Canada, ²Nephrology, University of Alberta, Edmonton, AB, Canada
*Purpose: The cost-effectiveness of kidney transplantation in the elderly in recipients of a kidney with a high kidney donor profile index (KDPI) is unknown. In…
2019 American Transplant Congress
Apixaban Therapy Is Safe And Effective In Most Organ Transplant Populations
A. Brown, S. Palkimas, W. Ally
University of Virginia Health System, Charlottesville, VA
*Purpose: The bleed rates from the apixaban pivotal trial were 12.1% for non-major and 3.8% major bleeds. However outcomes in transplant recipients are less defined,…
2019 American Transplant Congress
Identifying the Proverbial “Needle in the Arm” with Natural Language Processing
G. R. Vece, J. Foutz, A. Placona
Department of Research, United Network for Organ Sharing, Richmond, VA
*Purpose: Donors with a history of IVDU are associated with increased disease transmission risk; However, OPTN forms only request broad historical details relating to donor…